Proteogen Health Sciences India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.00 M
- Revenue Growth 276.30%
- Profit Growth 106.24%
- Ebitda 3184.55%
- Net Worth 5.59%
- Total Assets 9.03%
About Proteogen Health Sciences India
Proteogen Health Sciences India Private Limited (PHSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2018 (Six years and ten months 16 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹3.00 M.
Muniswamy Ravindra, Mahesh Krishnareddy, Ramachandran Prakasam, and Two other members serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U74999KA2018PTC111140
- Company No.
111140
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Proteogen Health Sciences India?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganesh Vsrinivasan  | Director | 14-Mar-2018 | Current |
| Muniswamy Ravindra | Director | 14-Mar-2018 | Current |
| Mahesh Krishnareddy | Director | 14-Mar-2018 | Current |
| Ramachandran Prakasam | Director | 06-Apr-2023 | Current |
| Sridhar Reddy | Director | 14-Mar-2018 | Current |
Financial Performance of Proteogen Health Sciences India.
Proteogen Health Sciences India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 276.3% increase. The company also saw a substantial improvement in profitability, with a 106.24% increase in profit. The company's net worth moved up by a moderate rise of 5.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Proteogen Health Sciences India?
In 2019, Proteogen Health Sciences India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Proteogen Biosystems (I) Private LimitedSridhar Reddy and Ganesh Vsrinivasan are mutual person
Charges (Loans)
₹3.00 M
₹0
Charges Breakdown by Lending Institutions
- Uco Bank : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Sep 2024 | Uco Bank | ₹3.00 M | Open |
How Many Employees Work at Proteogen Health Sciences India?
Unlock and access historical data on people associated with Proteogen Health Sciences India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Proteogen Health Sciences India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Proteogen Health Sciences India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
